As per Washington state guidance, masks are required regardless of vaccination status in all of our facilities. Please be aware that if you do not have a mask when you arrive we can provide one for you or reschedule your appointment. We appreciate your understanding!

Placebo-Contolled, Double-Blind, Phase 2a Study to Evaluate the Safety, Efficacy of Orally Administered AMT-101 in Subjects with Moderate to Severe Active UC

  • AMT-101 is orally administered
  • Males and females 18-80 with a diagnosis of moderately to severely active UC.
  • Cannot have failed or had inadequate response to both biologic and Tofacitnib for UC
  • Can be on stable doses of 5-ASA, Steroids, 6-MP, AZA and MTX

If you are interested in participating in clinical studies, please send an email to wagiresearch@washgi.com.

17 Locations Focused on Serving Your Needs

Email us at [email protected]